Home LiteratureArticle Details
PMID: 19345332 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

JunB protects against myeloid malignancies by limiting hematopoietic stem cell proliferation and differentiation without affecting self-renewal.

Cancer cell ·Vol. 15 ·No. 4 ·2009-04-07 ·Pages 341-52

Santaguida M, Schepers K, King B, Sabnis AJ, Forsberg EC, Attema JL, Braun BS, Passegué E

Abstract

Loss of the JunB/AP-1 transcription factor induces a myeloproliferative disease (MPD) arising from the hematopoietic stem cell (HSC) compartment. Here, we show that junB inactivation deregulates the cell-cycle machinery and increases the proliferation of long-term repopulating HSCs (LT-HSCs) without impairing their self-renewal or regenerative potential in vivo. We found that JunB loss destabilizes a complex network of genes and pathways that normally limit myeloid differentiation, leading to impaired responsiveness to both Notch and TGF-beta signaling due in part to transcriptional deregulation of the Hes1 gene. These results demonstrate that LT-HSC proliferation and differentiation are uncoupled from self-renewal and establish some of the mechanisms by which JunB normally limits the production of myeloid progenitors, hence preventing initiation of myeloid malignancies.

MeSH Terms
Animals Cell Cycle Cell Differentiation Cell Proliferation Cells, Cultured Hematopoietic Stem Cells/cytology,metabolism Mice Mice, Inbred C57BL Mice, Knockout Myeloproliferative Disorders/metabolism,prevention & control Proto-Oncogene Proteins c-jun/physiology Receptors, Notch/metabolism Signal Transduction Transforming Growth Factor beta/metabolism
Chemicals
Proto-Oncogene Proteins c-jun Receptors, Notch Transforming Growth Factor beta
Authors & Affiliations
8 authors, click to expand affiliations / ORCID
Santaguida Marianne
The Eli and Edythe Broad Center of Regeneration Medicine and Stem Cell Research, Division of Hematology/Oncology, Department of Medicine, University of California, San Francisco, CA 94143, USA.
Schepers Koen
King Bryan
Sabnis Amit J
Forsberg E Camilla
Attema Joanne L
Braun Benjamin S
Passegué Emmanuelle
References (31)
31 references, click to expand
  1. Targeting of CD44 eradicates human acute myeloid leukemic stem cells.
    Nat Med. 2006 Oct;12(10):1167-74 PMID: 16998484
  2. Cancer stem cells.
    N Engl J Med. 2006 Sep 21;355(12):1253-61 PMID: 16990388
  3. Canonical notch signaling is dispensable for the maintenance of adult hematopoietic stem cells.
    Cell Stem Cell. 2008 Apr 10;2(4):356-66 PMID: 18397755
  4. Regulation of immune responses by TGF-beta.
    Annu Rev Immunol. 1998;16:137-61 PMID: 9597127
  5. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression.
    EMBO J. 2000 Jun 15;19(12):2969-79 PMID: 10856241
  6. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3.
    J Cell Biol. 2003 Nov 24;163(4):723-8 PMID: 14638857
  7. How do stem cells find their way home?
    Blood. 2005 Sep 15;106(6):1901-10 PMID: 15890683
  8. Long-term lymphohematopoietic reconstitution by a single CD34-low/negative hematopoietic stem cell.
    Science. 1996 Jul 12;273(5272):242-5 PMID: 8662508
  9. Hematopoiesis: an evolving paradigm for stem cell biology.
    Cell. 2008 Feb 22;132(4):631-44 PMID: 18295580
  10. Hematopoietic stem cell self-renewal.
    Curr Opin Genet Dev. 2006 Oct;16(5):496-501 PMID: 16919448
  11. Uncertainty in the niches that maintain haematopoietic stem cells.
    Nat Rev Immunol. 2008 Apr;8(4):290-301 PMID: 18323850
  12. Quiescence of hematopoietic stem cells and maintenance of the stem cell pool is not dependent on TGF-beta signaling in vivo.
    Exp Hematol. 2005 May;33(5):592-6 PMID: 15850837
  13. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
    Cell. 2004 Oct 29;119(3):431-43 PMID: 15507213
  14. Integration of Notch and Wnt signaling in hematopoietic stem cell maintenance.
    Nat Immunol. 2005 Mar;6(3):314-22 PMID: 15665828
  15. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia.
    Blood. 1999 Sep 15;94(6):2056-64 PMID: 10477735
  16. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation.
    Nat Rev Genet. 2008 Feb;9(2):115-28 PMID: 18202695
  17. In vivo proliferation and cell cycle kinetics of long-term self-renewing hematopoietic stem cells.
    Proc Natl Acad Sci U S A. 1999 Mar 16;96(6):3120-5 PMID: 10077647
  18. SLAM family receptors distinguish hematopoietic stem and progenitor cells and reveal endothelial niches for stem cells.
    Cell. 2005 Jul 1;121(7):1109-21 PMID: 15989959
  19. Haematopoietic stem cells do not asymmetrically segregate chromosomes or retain BrdU.
    Nature. 2007 Sep 13;449(7159):238-42 PMID: 17728714
  20. Cancer stem cells: lessons from leukemia.
    Trends Cell Biol. 2005 Sep;15(9):494-501 PMID: 16084092
  21. Stem-cell ageing modified by the cyclin-dependent kinase inhibitor p16INK4a.
    Nature. 2006 Sep 28;443(7110):421-6 PMID: 16957735
  22. Global analysis of proliferation and cell cycle gene expression in the regulation of hematopoietic stem and progenitor cell fates.
    J Exp Med. 2005 Dec 5;202(11):1599-611 PMID: 16330818
  23. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression.
    EMBO J. 2000 May 2;19(9):2056-68 PMID: 10790372
  24. Essential role of Jun family transcription factors in PU.1 knockdown-induced leukemic stem cells.
    Nat Genet. 2006 Nov;38(11):1269-77 PMID: 17041602
  25. Transforming growth factor beta 1 directly and reversibly inhibits the initial cell divisions of long-term repopulating hematopoietic stem cells.
    Blood. 1996 Jul 1;88(1):82-8 PMID: 8704205
  26. Signaling pathways governing stem-cell fate.
    Blood. 2008 Jan 15;111(2):492-503 PMID: 17914027
  27. New evidence supporting megakaryocyte-erythrocyte potential of flk2/flt3+ multipotent hematopoietic progenitors.
    Cell. 2006 Jul 28;126(2):415-26 PMID: 16873070
  28. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
    Blood. 2003 Apr 15;101(8):3205-11 PMID: 12506033
  29. Cell cycle promoting activity of JunB through cyclin A activation.
    J Biol Chem. 2002 Sep 27;277(39):35961-8 PMID: 12121977
  30. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.
    Cell. 2001 Jan 12;104(1):21-32 PMID: 11163237
  31. The transcription factor EGR1 controls both the proliferation and localization of hematopoietic stem cells.
    Cell Stem Cell. 2008 Apr 10;2(4):380-91 PMID: 18397757
Article Info
Journal
Cancer cell
Abbr.
Cancer Cell
ISSN
1878-3686
Published
2009-04-07
Pages
341-52
Language
English
Region
United States
NLM ID
101130617
PMCID
PMC2669108
Subset
IM
Grants
NHLBI NIH HHS · R01 HL092471 · United States
NHLBI NIH HHS · R01 HL092471-01 · United States
NHLBI NIH HHS · HL092471 · United States
Corrections
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]